Grace Therapeutics, Inc. Increase (Decrease) in Prepaid Expense
Grace Therapeutics, Inc. (GRCE) reported Increase (Decrease) in Prepaid Expense of $174.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-13
- Grace Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was $174.00K, a 270.21% increase year-over-year.
- Grace Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was -$136.00K.
- Grace Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was $103.00K, a 2.83% decline year-over-year.
- Grace Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was -$84.00K.
- Grace Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2026 was -$70.00K, a 141.18% decline from fiscal 2025.
- Grace Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2025 was $170.00K.
- Grace Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2024 was -$315.00K.
- Grace Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2023 was -$72.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 3 month as first filed | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 9 month as first filed | Increase (Decrease) in Prepaid Expense 12 month | Increase (Decrease) in Prepaid Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $174.00K 10-Q · filed 2026-08-13 | $38.00K derived: sum of 2 quarters · filed 2026-08-13 | $141.00K derived: sum of 3 quarters · filed 2026-08-13 | $57.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | -$33.00K derived: sum of 2 quarters · filed 2026-06-18 | -$117.00K derived: sum of 3 quarters · filed 2026-06-18 | -$70.00K 10-K · filed 2026-06-18 | ||||
| 2025-12-31 | $103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $19.00K derived: sum of 2 quarters · filed 2026-02-12 | $66.00K 10-Q · filed 2026-02-12 | -$64.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-09-30 | -$84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | -$37.00K 10-Q · filed 2025-11-13 | -$167.00K derived: sum of 3 quarters · filed 2026-08-13 | -$61.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $47.00K 10-Q · filed 2026-08-13 | -$83.00K derived: sum of 2 quarters · filed 2026-08-13 | $23.00K derived: sum of 3 quarters · filed 2026-08-13 | -$122.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | -$24.00K derived: sum of 2 quarters · filed 2026-06-18 | -$169.00K derived: sum of 3 quarters · filed 2026-06-18 | $170.00K 10-K · filed 2026-06-18 | ||||
| 2024-12-31 | $106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | -$39.00K derived: sum of 2 quarters · filed 2026-02-12 | $300.00K 10-Q · filed 2026-02-12 | -$228.00K derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-09-30 | -$145.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | $194.00K 10-Q · filed 2025-11-13 | -$334.00K derived: sum of 3 quarters · filed 2025-11-13 | -$567.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $339.00K 10-Q · filed 2025-08-12 | -$189.00K derived: sum of 2 quarters · filed 2025-08-12 | -$422.00K derived: sum of 3 quarters · filed 2025-08-12 | -$505.00K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$528.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-23 | -$761.00K derived: sum of 2 quarters · filed 2025-06-23 | -$844.00K derived: sum of 3 quarters · filed 2025-06-23 | -$315.00K 10-K · filed 2025-06-23 | ||||
| 2023-12-31 | -$233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | -$316.00K derived: sum of 2 quarters · filed 2025-02-13 | $213.00K 10-Q · filed 2025-02-13 | -$241.00K derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-09-30 | -$83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-13 | $446.00K 10-Q · filed 2024-11-13 | -$446.00K 10-Q · filed 2023-11-13 | -$8.00K derived: sum of 3 quarters · filed 2024-11-13 | $1.08M derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $529.00K 10-Q · filed 2024-08-09 | -$529.00K 10-Q · filed 2023-08-11 | $75.00K derived: sum of 2 quarters · filed 2024-08-09 | $1.16M derived: sum of 3 quarters · filed 2024-08-09 | $1.30M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | -$454.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-21 | $632.00K derived: sum of 2 quarters · filed 2024-06-21 | $767.00K derived: sum of 3 quarters · filed 2024-06-21 | -$72.00K 10-K · filed 2024-06-21 | $72.00K 10-K · filed 2023-06-23 | |||
| 2022-12-31 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | $1.22M derived: sum of 2 quarters · filed 2024-02-12 | $382.00K 10-Q · filed 2024-02-12 | -$382.00K 10-Q · filed 2023-02-14 | $1.51M derived: sum of 4 quarters · filed 2024-02-12 | |||
| 2022-09-30 | $135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | -$704.00K 10-Q · filed 2023-11-13 | $423.00K derived: sum of 3 quarters · filed 2023-11-13 | $92.00K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$839.00K 10-Q · filed 2023-08-11 | $288.00K derived: sum of 2 quarters · filed 2023-08-11 | -$43.00K derived: sum of 3 quarters · filed 2023-08-11 | $1.14M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-23 | $796.00K derived: sum of 2 quarters · filed 2023-06-23 | $1.98M derived: sum of 3 quarters · filed 2023-06-23 | -$380.00K 10-K · filed 2023-06-23 | ||||
| 2021-12-31 | -$331.00K 10-Q · filed 2022-02-14 | $855.00K derived: sum of 2 quarters · filed 2022-02-14 | -$1.51M 10-Q · filed 2023-02-14 | $1.51M 10-Q · filed 2022-02-14 | $1.40M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-09-30 | $1.19M 10-Q · filed 2021-11-10 | -$1.84M 10-Q · filed 2022-11-14 | $1.84M 10-Q · filed 2021-11-10 | $1.73M derived: sum of 3 quarters · filed 2022-08-11 | $1.75M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-06-30 | -$653.00K 10-Q · filed 2022-08-11 | $653.00K 10-Q · filed 2021-08-12 | $540.00K derived: sum of 2 quarters · filed 2022-08-11 | $563.00K derived: sum of 3 quarters · filed 2022-08-11 | $313.00K derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-21 | $1.22M derived: sum of 2 quarters · filed 2022-06-21 | $966.00K derived: sum of 3 quarters · filed 2022-06-21 | $672.00K 10-K · filed 2022-06-21 | -$672.00K 10-K · filed 2021-06-22 | |||
| 2020-12-31 | $23.00K 10-Q · filed 2022-02-14 | -$227.00K derived: sum of 2 quarters · filed 2022-02-14 | -$521.00K 10-Q · filed 2022-02-14 | -$854.00K derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-09-30 | -$250.00K 10-Q · filed 2021-11-10 | -$544.00K 10-Q · filed 2021-11-10 | -$877.00K derived: sum of 3 quarters · filed 2021-11-10 | $197.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$294.00K 10-Q · filed 2021-08-12 | -$627.00K derived: sum of 2 quarters · filed 2021-08-12 | $447.00K derived: sum of 3 quarters · filed 2021-08-12 | $262.00K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-22 | $741.00K derived: sum of 2 quarters · filed 2021-06-22 | $556.00K derived: sum of 3 quarters · filed 2021-06-22 | $185.00K 10-K · filed 2021-06-22 | ||||
| 2019-12-31 | $1.07M 10-Q · filed 2021-02-09 | $889.00K derived: sum of 2 quarters · filed 2021-02-09 | $518.00K 10-Q · filed 2021-02-09 | |||||
| 2019-09-30 | -$185.00K 10-Q · filed 2020-11-16 | -$556.00K 10-Q · filed 2020-11-16 | ||||||
| 2019-06-30 | -$371.00K 10-Q · filed 2020-08-13 | |||||||
| 2019-03-31 | $530.00K 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |